Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Research & Development: 2011-2024

Historic Research & Development for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to $933,902.

  • Sunshine Biopharma's Research & Development fell 5.59% to $119,298 in Q3 2025 from the same period last year, while for Sep 2025 it was $680,079, marking a year-over-year decrease of 57.52%. This contributed to the annual value of $933,902 for FY2024, which is 49.68% down from last year.
  • Sunshine Biopharma's Research & Development amounted to $933,902 in FY2024, which was down 49.68% from $1.9 million recorded in FY2023.
  • Sunshine Biopharma's Research & Development's 5-year high stood at $1.9 million during FY2023, with a 5-year trough of $1,728 in FY2020.
  • For the 3-year period, Sunshine Biopharma's Research & Development averaged around $1.2 million, with its median value being $933,902 (2024).
  • As far as peak fluctuations go, Sunshine Biopharma's Research & Development slumped by 88.63% in 2020, and later skyrocketed by 38,800.98% in 2021.
  • Over the past 5 years, Sunshine Biopharma's Research & Development (Yearly) stood at $1,728 in 2020, then soared by 38,800.98% to $672,209 in 2021, then rose by 20.77% to $811,858 in 2022, then soared by 128.59% to $1.9 million in 2023, then plummeted by 49.68% to $933,902 in 2024.